PRIVIUM FUND MANAGEMENT B.V. – Neurocrine Biosciences, Inc. Transaction History
PRIVIUM FUND MANAGEMENT B.V. portfolio value:
$1.76M
portfolio value
PRIVIUM FUND MANAGEMENT B.V. quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +24.76% | 3.4K shares | 421K | $106.21 | 17.13K |
| Q2 2022 | share | 0.00% | 0 shares | 52K | $97.48 | 13.73K | |
| Q1 2022 | share | Decrease | -77.95% | -48.54K shares | -3.98M | $93.75 | 13.73K |
| Q4 2021 | share | Increase | 0.00% | 62.27K shares | 5.27M | $84.63 | 62.27K |